Libby Echo:Prio vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Dyad Medical
VS
by Cardiomo, Inc.

AI Verdict

Libby Echo:Prio is an AI platform for analyzing existing echocardiogram images to provide decision support and automated measurements for clinicians. Cardiomo, on the other hand, is a medical-grade wearable device with an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts. While both focus on cardiology and leverage AI, Libby Echo:Prio is a diagnostic aid for interpreting medical imaging, whereas Cardiomo is a remote monitoring and early detection tool.

Choose Libby Echo:Prio if…

Choose Libby Echo:Prio if your clinical setting requires rapid, AI-powered analysis of echocardiograms for decision support and automated cardiac measurements. This cloud-based platform is ideal for cardiologists and critical care specialists seeking consistent analysis, reduced variability, and an immediate second opinion to enhance diagnostic confidence and workflow efficiency.

View Libby Echo:Prio →

Choose Cardiomo if…

Choose Cardiomo if you need a comprehensive, continuous, and remote heart health monitoring solution for patients, particularly in cardiology, geriatrics, or internal medicine. This medical-grade wearable device and AI platform are best suited for detecting cardiovascular diseases, providing real-time alerts to users and caregivers, and offering insights into vital signs like ECG, heart rate, respiration, and skin temperature for proactive health management.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Libby Echo:Prio Cardiomo
Pricing Custom Contact for pricing
Deployment Cloud-based Cloud-based with wearable device and mobile app
BAA Available No AI-estimated Unknown
FDA Status Yes AI-estimated Unknown
HIPAA No AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Libby Echo:Prio Cardiomo
Name Libby Echo:Prio Cardiomo
Company Dyad Medical Cardiomo, Inc.
Description FDA-cleared, cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians. A medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Key Features AI-powered cardiac image analysis, Cloud-based platform for remote access from any device, Fast, data-driven echocardiogram image analysis, Decision-making support for cardiac function quantification, Automated estimation of cardiac measurements, Embedded in existing clinical workflows, Provides an immediately-available second opinion, Consistent analysis and low inter/intra-analyst variability Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)

Videos

Demos, reviews, and walkthroughs featuring Libby Echo:Prio and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Libby Echo:Prio is designed to be embedded in current workflows for imaging operators, physicians, and researchers, providing automated cardiac measurements and decision support for echocardiogram analysis. Cardiomo, with its wearable device and mobile app, focuses on continuous remote monitoring and real-time alerts. While Cardiomo offers a RESTful API, webhooks, and pre-built integrations for connecting to existing platforms, the depth of its EHR integration for automated data flow into clinical notes and billing would need further inquiry.
Libby Echo:Prio provides fast, data-driven echocardiogram analysis with consistent analysis and low inter/intra-analyst variability, offering an immediately available second opinion for cardiac function quantification. Cardiomo claims 99.63% accuracy in detecting cardiac events and provides continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature) with proprietary algorithms trained to detect arrhythmias and other cardiac events.
Libby Echo:Prio is designed to be embedded in existing clinical workflows, suggesting an aim for ease of use. For AI-guided echocardiography tools in general, studies indicate that novice operators can achieve high-quality imaging after a relatively short standardized training period (e.g., eight hours). Cardiomo is described as user-friendly and practical, with its mobile application providing patient-friendly information.
While specific details on customer support for Libby Echo:Prio are not provided, Cardiomo emphasizes professional support, including professional-grade reporting, integration with clinical workflows, and expert technical support, as a characteristic of medical-grade devices.
Cardiomo has been successfully tested in pilot projects with healthcare institutions in Ukraine, Austria, and Portugal, and has received over 1600 pre-orders. They also mention having first clients who experienced advantages of their initial series of devices. Specific customer references or detailed case studies for Libby Echo:Prio are not provided in the given information.
Libby Echo:Prio's cloud-based nature allows for remote access from any device, which could facilitate multi-site access and consistent analysis regardless of operator skill level. Cardiomo's cloud-based platform and mobile app also inherently support remote access and monitoring, which would be beneficial for multi-site deployments.

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.